
White House withdraws Heidi Overton's FDA nomination on eve of Senate committee vote
Key Takeaways
- Senate math on HELP made confirmation unlikely, with Republican skepticism and no expected Democratic support prompting withdrawal before committee action.
- Bill Cassidy emphasized leadership capability and vaccine policy, criticizing support for breaking up combination vaccines and pressing on independence from presidential pressure.
The decision leaves the FDA under acting leadership as Senate Republicans race to confirm nominees before Democrats take control in January.
The White House on Nov. 17 withdrew the nomination of Heidi Overton, M.D., Ph.D., to lead the Food and Drug Administration (FDA), one day before the Senate Health, Education, Labor and Pensions (HELP) Committee was scheduled to vote on whether to send her to the full Senate.
Overton "lacks the support on the Hill to move forward with her confirmation," a senior administration official told Axios, which
Republicans hold a one-vote majority on the committee, so a single GOP defection would have sunk the nomination if every Democrat voted no,
Overton, deputy director of the White House Domestic Policy Council, was
Overton trained as a general surgery resident at Johns Hopkins, is board-certified in public health and general preventive medicine and served as a White House fellow from 2019 to 2020,
She holds a Ph.D. in clinical investigation from the
Cassidy's doubts centered on vaccines
On Aug. 19, the day Trump announced the pick, HELP Committee Chair Sen. Bill Cassidy, M.D. (R-Louisiana), wrote on social media that while he respected Overton's experience as a physician, her "lack of managerial experience does not prepare her well" to lead an agency already dealing with staffing and morale problems,
In the same post, Cassidy called her support for Trump's plan to break up combination vaccines, including the measles, mumps and rubella (MMR) shot, "almost disqualifying,"
At her Sept. 24 confirmation hearing, Cassidy told Overton that Robert F. Kennedy Jr., secretary of the Department of Health and Human Services (HHS), had backed away from vaccine-access promises he made to the senator, then asked what she would do if Trump pushed her to break commitments she made to the committee.
Overton said she would give the president her best advice and follow the legal requirements of the commissioner's role,
She told the panel the MMR vaccine and every other vaccine on the U.S. market are safe and effective,
Cassidy lost his June primary and has weeks left in his term, the AP reported. Asked about the nomination by Face the Nation on Nov. 15, he said he was still working the phones and noted that failing to confirm a commissioner would mean relying on acting leadership,
The same day, he said he had heard from people who think deeply about the FDA "who have said it's better to have a steady hand," while others disagreed,
Abortion pill and vaping questions
Sen. Josh Hawley (R-Missouri) questioned whether Overton's hearing statements on mifepristone matched what the administration was arguing in ongoing litigation,
Sen. Patty Murray (D-Washington) asked about a 2023 article in which Overton called mifepristone dangerous to women,
Cassidy told Overton he wanted the next commissioner to require an in-person ultrasound before mifepristone is dispensed and to have physicians report adverse events tied to the drug, Roll Call reported.
Murkowski warned that requiring in-person dispensing would put a rural state such as Alaska in a difficult position,
Multiple Republican senators had concerns about Overton's stances on abortion, vaccines and vaping,
The network also reported that Overton helped carry out Trump's pro-vaping policies on the Domestic Policy Council. Makary has said tobacco companies pressured him to approve fruit-flavored vapes and that he refused, according to CBS.
Opposition from Make America Healthy Again allies
Calley Means, a former HHS adviser and prominent voice in Kennedy's Make America Healthy Again (MAHA) movement, urged his followers to block the nomination. "Heidi Overton was the biggest block to MAHA policies I encountered in the government," Means said, according to CBS News.
Means accused White House aides, including Overton, of helping advance the Supreme Court's
White House spokesperson Kush Desai said in August that Overton had been integral to keeping the administration's policies "grounded in Gold Standard Science,"
What comes next for the agency
The White House has talked with possible replacements, including candidates who could serve as acting commissioner without Senate confirmation, and Sen. Roger Marshall, M.D. (R-Kansas), is reportedly considering the job, CBS News reported. In September, a New York Times analysis of Kansas court records found that Marshall and the obstetrics practice he owned
Republicans are trying to confirm Trump's pending nominees before the new Congress is seated in January,
The administration previously
If confirmed, Overton would have been responsible for steering the agency through new vaccine recommendations and revamped rare disease drug reviews,
Related to this article









